Medicine and Dentistry
Neoplasm
100%
Disease
48%
Malignant Neoplasm
47%
Surgery
45%
Computer Assisted Tomography
42%
Non Small Cell Lung Cancer
33%
Recurrent Disease
33%
Lung Cancer
33%
Magnetic Resonance Imaging
32%
Overall Survival
28%
Cancer Cell
26%
Adverse Event
25%
Lung Transplantation
25%
Diagnosis
23%
Retrospective Study
22%
Symptom
21%
Bleeding
21%
Odds Ratio
20%
Hepatocellular Carcinoma
20%
Survival Rate
20%
In Vitro
20%
Metastatic Carcinoma
20%
Observational Study
19%
Infection
19%
Stomach Cancer
18%
Radiofrequency Ablation
18%
Radiation Therapy
17%
Optical Coherence Tomography
17%
Epidermal Growth Factor Receptor
17%
Biopsy
16%
Injury
16%
Endoscopic Submucosal Dissection
15%
Arm
15%
Prognostic Factor
14%
Chemoradiotherapy
14%
Knee
14%
Multivariate Analysis
13%
Prevalence
13%
Squamous Cell Carcinoma
13%
Lymph Node Metastasis
13%
Cohort Analysis
13%
Hazard Ratio
12%
Cross Sectional Study
12%
Clinical Trial
12%
Soft Tissue Sarcoma
12%
Biological Marker
12%
Mouth Squamous Cell Carcinoma
11%
Telomerase
11%
Pediatrics
11%
Esophageal Cancer
11%
Brugada Syndrome
11%
Programmed Cell Death
11%
Dentin
11%
Breast Cancer
11%
Cancer
11%
Immunohistochemistry
10%
Pancreas Cancer
10%
Chronic Kidney Disease
10%
Elderly Patient
10%
Periodontitis
10%
Tumor Cell
10%
Quality of Life
10%
Pulmonary Hypertension
10%
Cisplatin
10%
Fibroblast
10%
Gene Expression
10%
Heart Failure
10%
Edentulism
10%
Lower Jaw
9%
Suture Material
9%
Diabetes Mellitus
9%
Osteosarcoma
9%
Progression Free Survival
9%
Adenoviridae
9%
Apoplexy
9%
Prospective Cohort Study
9%
Salicylic Acid
9%
Combination Therapy
9%
Epileptic Absence
9%
Lymph Node
9%
Randomized Controlled Trial
9%
Logistic Regression Analysis
9%
Rheumatoid Arthritis
8%
MALT Lymphoma
8%
Immunoglobulin G4
8%
COVID-19
8%
Lung Metastasis
8%
Body Mass Index
8%
Endoscopic Ultrasound
8%
Chondrocyte
8%
Postoperative Complication
8%
Cancer Surgery
8%
Bone Tissue
8%
Retrospective Cohort Study
8%
Atrial Septal Defect
8%
Resuscitation
8%
Carcinoma
8%
Liver Transplantation
8%
Nivolumab
8%
Tumor Progression
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
73%
Neoplasm
67%
Malignant Neoplasm
58%
Disease
42%
Non Small Cell Lung Cancer
37%
Lung Cancer
31%
Chemotherapy
30%
Epidermal Growth Factor Receptor
26%
Liver Cell Carcinoma
23%
Inflammation
22%
Overall Survival
20%
Mouse Model
19%
Adverse Event
19%
Symptom
17%
Infection
16%
Recurrent Disease
16%
Protein P53
15%
Cytokine
15%
Receptor
14%
Combination Therapy
14%
Prevalence
14%
Clinical Trial
13%
Antioxidant
13%
Biological Marker
13%
Cisplatin
12%
Survival Rate
12%
Tumor Necrosis Factor
12%
Adenoviridae
12%
Stomach Cancer
12%
Chemoradiation Therapy
11%
Observational Study
11%
Cohort Study
11%
Periodontitis
11%
Doxorubicin
10%
Breast Cancer
10%
Retinoid X Receptor
10%
Histamine
10%
Telomerase
10%
Progression Free Survival
10%
Nonalcoholic Fatty Liver
10%
Chronic Kidney Failure
10%
Hepatitis C Virus
10%
Normal Human
9%
Alzheimer's Disease
9%
Pancreas Cancer
9%
Tumor Growth
9%
Parkinson's Disease
9%
Pulmonary Hypertension
9%
Diabetes Mellitus
8%
Interferon
8%
Retrospective Study
8%
Injury
8%
Esophagus Cancer
8%
Lipopolysaccharide
8%
Therapeutic Effect
8%
Cardiovascular Disease
8%
Neuroprotective Agent
8%
Heart Failure
8%
Remission
8%
Pharmacokinetics
7%
Dopamine Receptor Stimulating Agent
7%
Reactive Oxygen Metabolite
7%
Randomized Controlled Trial
7%
Calcium Ion
7%
Interleukin 18
7%
Syndrome
7%
Histidine
7%
Glycoprotein
7%
Asthma
7%
Ischemia
7%
Oncolytic Adenovirus
7%
Brugada Syndrome
7%
Paclitaxel
7%
Proteinase
7%
Receptor Agonist
7%
Cross-Sectional Study
7%
Interleukin 6
7%
Intercellular Adhesion Molecule 1
7%
Acute Kidney Failure
7%
Tumor Suppressor Protein
6%
Coronary Artery Disease
6%
Vasculotropin
6%
Monoclonal Antibody
6%
Rheumatoid Arthritis
6%
Immune Checkpoint Inhibitor
6%
Phosphotransferase
6%
microRNA
6%
Metastasis
6%
Virotherapy
6%
Squamous Cell Carcinoma
6%
Bleeding
6%
Edaravone
6%
Epidermal Growth Factor Receptor Kinase Inhibitor
6%
Fibrosis
6%
Adenovirus Vector
6%
Fluorine 18
6%
Gamma Urogastrone
6%
Gefitinib
6%
Carcinogenesis
6%
Atherosclerosis
6%
Keyphrases
Japan
28%
Non-small Cell Lung Cancer (NSCLC)
15%
Tumor
14%
Confidence Interval
13%
Okayama
9%
Oxidative Stress
9%
Lung Cancer
8%
Histamine
8%
Lung Transplantation
8%
Clinical Outcomes
8%
Risk Factors
7%
Overall Survival
7%
Telomerase
7%
Medial Meniscus Posterior Root Tear
7%
Adenovirus
7%
Cisplatin
6%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
6%
Cancer Cells
6%
Odds Ratio
6%
Japanese Patients
6%
Apoptosis
6%
EGFR mutation
6%
Hazard Ratio
5%
High Mobility Group Box 1 (HMGB1)
5%
Radiofrequency Ablation
5%
CCN2
5%
Gastric Cancer
5%
Antitumor Effect
5%
Gene Expression
5%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
5%
Tumor Necrosis Factor-α
5%
Computed Tomography
5%